Neurogenic hypertension

Common Name(s)

Neurogenic hypertension

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Neurogenic hypertension" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Neurogenic hypertension" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Neurogenic hypertension" returned 12 free, full-text research articles on human participants. First 3 results:

Clinical Relevance and Role of Neuronal AT Receptors in ADAM17-Mediated ACE2 Shedding in Neurogenic Hypertension.
 

Author(s): Jiaxi Xu, Srinivas Sriramula, Huijing Xia, Lisa Moreno-Walton, Frank Culicchia, Oliver Domenig, Marko Poglitsch, Eric Lazartigues

Journal: Circ. Res.. 2017 Jun;121(1):43-55.

 

Neurogenic hypertension is characterized by an increase in sympathetic activity and often resistance to drug treatments. We previously reported that it is also associated with a reduction of angiotensin-converting enzyme type 2 (ACE2) and an increase in a disintegrin and metalloprotease ...

Last Updated: 31 Dec 1969

Go To URL
Brain angiotensin-converting enzyme type 2 shedding contributes to the development of neurogenic hypertension.
 

Author(s): Huijing Xia, Srinivas Sriramula, Kavaljit H Chhabra, Eric Lazartigues

Journal: Circ. Res.. 2013 Oct;113(9):1087-1096.

 

Overactivity of the brain renin-angiotensin system is a major contributor to neurogenic hypertension. Although overexpression of angiotensin-converting enzyme type 2 (ACE2) has been shown to be beneficial in reducing hypertension by transforming angiotensin II into angiotensin-(1-7), ...

Last Updated: 31 Dec 1969

Go To URL
Microvascular decompression surgery for refractory hypertension of neurogenic causes.
 

Author(s): Jessica Barley, Charles Ellis

Journal: J Clin Hypertens (Greenwich). 2013 Mar;15(3):217.

 

Last Updated: 31 Dec 1969

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Neurogenic hypertension" returned 10 free, full-text review articles on human participants. First 3 results:

Mitochondria and Reactive Oxygen Species Contribute to Neurogenic Hypertension.
 

Author(s): Samuel H H Chan, Julie Y H Chan

Journal: Physiology (Bethesda). 2017 Jul;32(4):308-321.

 

Beyond its primary role as fuel generators, mitochondria are engaged in a variety of cellular processes, including redox homeostasis. Mitochondrial dysfunction, therefore, may have a profound impact on high-energy-demanding organs such as the brain. Here, we review the roles of mitochondrial ...

Last Updated: 31 Dec 1969

Go To URL
Neurogenic hypertension and the secrets of respiration.
 

Author(s): Benedito H Machado, Daniel B Zoccal, Davi J A Moraes

Journal: Am. J. Physiol. Regul. Integr. Comp. Physiol.. 2017 06;312(6):R864-R872.

 

Despite recent advances in the knowledge of the neural control of cardiovascular function, the cause of sympathetic overactivity in neurogenic hypertension remains unknown. Studies from our laboratory point out that rats submitted to chronic intermittent hypoxia (CIH), an experimental ...

Last Updated: 31 Dec 1969

Go To URL
The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension.
 

Author(s): Christopher H Gibbons, Peter Schmidt, Italo Biaggioni, Camille Frazier-Mills, Roy Freeman, Stuart Isaacson, Beverly Karabin, Louis Kuritzky, Mark Lew, Phillip Low, Ali Mehdirad, Satish R Raj, Steven Vernino, Horacio Kaufmann

Journal: J. Neurol.. 2017 Aug;264(8):1567-1582.

 

Neurogenic orthostatic hypotension (nOH) is common in patients with neurodegenerative disorders such as Parkinson's disease, multiple system atrophy, pure autonomic failure, dementia with Lewy bodies, and peripheral neuropathies including amyloid or diabetic neuropathy. Due to the ...

Last Updated: 31 Dec 1969

Go To URL
 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Effects of Melatonin to Reduce Nocturnal Hypertension in Patients With Neurogenic Orthostatic Hypotension
 

Status: Recruiting

Condition Summary: Hypotension, Orthostatic; Hypertension; Autonomic Nervous System Diseases

 

Last Updated: 7 Mar 2018

Go to URL
Fesoterodine for Amelioration of Autonomic Dysreflexia (AD) Following Spinal Cord Injury (SCI)
 

Status: Recruiting

Condition Summary: Autonomic Dysreflexia

 

Last Updated: 30 Apr 2018

Go to URL